首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Transfusion medicine and hemotherapy

缩写:TRANSFUS MED HEMOTH

ISSN:1660-3796

e-ISSN:1660-3818

IF/分区:1.9/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引926
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Philipp Berg,Sonja Schönefeld,Gabriele Ruppert-Seipp et al. Philipp Berg et al.
Introduction: Regulatory activities aim to facilitate the safe use of novel therapeutics such as genetically engineered chimeric antigen receptor (CAR)-T cells. Toxicities associated with CAR-T-cell therapies have led to ...
Angelo D&#x;Alessandro Angelo D&#x;Alessandro
Background: Blood transfusion is a life-saving intervention for millions of recipients worldwide. Over the last 15 years, the advent of high-throughput, affordable omics technologies - including genomics, proteomics, lipi...
Elisabeth Kapfhammer,Thomas Pfammatter,Romana Brun et al. Elisabeth Kapfhammer et al.
Introduction: Postpartum hemorrhage (PPH) is the leading cause of peripartal maternal mortality and accounts for 25% of all maternal deaths worldwide. The most common reasons of PPH are uterine atony, retained placenta, o...
Eva Laurén,Lotta Sankkila,Ville Pettilä et al. Eva Laurén et al.
Introduction: Red blood cell (RBC) transfusion may affect the recipient immune system. During RBC storage in an unphysiological environment, RBC quality and function are impaired, the cells bleb extracellular vesicles (EV...
Arianna Miglio,Valentina Cremonini,Leonardo Leonardi et al. Arianna Miglio et al.
Background: Omics technologies represent a new analytical approach that allows a full cellular readout through the simultaneous analysis of thousands of molecules. The application of such technologies represents a flouris...
Marcelle G M Lopes,Steffen M Recktenwald,Greta Simionato et al. Marcelle G M Lopes et al.
Background: "Artificial intelligence" and "big data" increasingly take the step from just being interesting concepts to being relevant or even part of our lives. This general statement holds also true for transfusion medi...
Stefano Orru&#x;,Doris Oberle,Margarethe Heiden et al. Stefano Orru&#x; et al.
Introduction: Following the first assessment of the effects of safety measures taken against transfusion-transmitted bacterial infections (TTBI), the Paul-Ehrlich-Institut (PEI) decided to newly analyze risk minimization ...
Erwin Strasser Erwin Strasser
Background: Therapeutic plasma exchange (TPE) is a well-known apheresis technology since many years and is available worldwide. Myasthenia gravis is one of the first neurological diseases successfully treated with TPE. TP...
Washington T Samukange,Chancelar Kafere,Kristina Heinrich et al. Washington T Samukange et al.
Background: Assuring the quality and safety of blood and blood components is an essential element of health care in all countries and requires government commitment and legal frameworks. Ineffective regulation of blood an...